Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
批准号:
9084502
负责人:
DAVID A WOHL
金额:
$18.24万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-15 至 2019-04-30
关键词:
AIDS preventionAcquired Immunodeficiency SyndromeAddressAdoptedAffectAnti-Retroviral AgentsAreaAwardBackCaringCharacteristicsClinicalClinical InvestigatorClinical ResearchClinical Trials UnitCommunicable DiseasesCommunitiesContinuity of Patient CareCounselingCriminal JusticeData AnalysesData CollectionDetectionDevelopmentDiagnosisDirectly Observed TherapyDiscriminationDiseaseDoctor of PhilosophyEducational process of instructingEnvironmentEpidemicEvidence based interventionFacultyFailureFellowshipFosteringFundingFutureGap JunctionsGoalsHIVHIV InfectionsHuman immunodeficiency virus testImprisonmentIndividualInfectious Diseases ResearchIntakeInterventionInterviewInvestigationLeadershipLeftMaintenanceMental disordersMentorsMentorshipMethodologyMethodsModelingModificationMotivationNorth CarolinaParticipantPerceptionPersonal SatisfactionPersonsPopulationPositioning AttributePovertyPreventionPrisonerPrisonsPublic HealthPublic Health SchoolsPublicationsRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesRiskSelf MedicationServicesSiteSubstance abuse problemSystemTechniquesTestingTimeTrainingTraining ProgramsTraining and EducationTranslatingUnited States National Institutes of HealthUniversitiesVirusVulnerable PopulationsWomanWorkarmbasecareercohortcorrectional systemdesignelectronic dataexperiencefallsimprovedinterestmedical schoolsmenmid-career facultynext generationpatient oriented researchprogramspublic health relevancescreeningskillssocial stigmastudent mentoringsubstance abuse treatmenttransmission processviral transmissionworking group
中文摘要
描述(由申请人提供):David Alain Wohl,医学博士,北卡罗来纳大学(UNC)传染病部副教授,提交此申请,申请K24中期职业奖。K24的目的是使接受者能够:a)投入更多的时间来增强他们在面向患者的研究(POR)方面的能力;b)指导新的临床研究者进行POR。Wohl博士是全国公认的HIV临床研究思想领袖,特别是在探索监禁与HIV之间的关系方面。在这个应用程序中,他建议发展技能,这将有助于他未来在这一重要研究领域的工作,包括定性数据收集和分析方法,更高层次的分析技术,以及有效领导的策略。他将扩大已有的指导记录,以发展更大的能力和研究机会,以促进早期研究者的研究事业。Wohl博士是一名高效的HIV临床研究人员,并建立了UNC作为HIV相关矫正研究的主要中心。自2003年以来,他一直在美国国立卫生研究院(nih)资助下进行研究,旨在优化艾滋病毒检测和对刑事司法系统中涉及的人的护理,这是一个普遍存在药物滥用和精神健康障碍的人群,并直接将三项r01支持的调查结果转化为NC监狱系统实践的改进。根据他的调查,NC监狱系统采用了抗逆转录病毒自我药物治疗,而不是普遍的直接观察治疗,在入院时转向自愿选择退出艾滋病毒检测,并为感染艾滋病毒的释放者开发了新的过渡性护理模式。此外,Wohl博士在新研究人员的教学和指导方面有着良好的记录,支持被指导者获得奖项和第一作者出版物,以及这些有才华的研究人员的独立性。指导计划/环境:该应用程序将利用北卡罗来纳大学广泛的培训资源,包括艾滋病研究中心(CFAR)、公共卫生学院K30培训计划、医学院医学博士/博士课程和北卡罗来纳大学传染病研究奖学金——Wohl博士都深入参与其中。作为UNC CFAR监狱工作组的创始人和联合主任,UNC艾滋病临床试验单元的现场负责人,以及NC艾滋病培训和教育中心(ATEC)的主任,Wohl博士能够很好地接触和指导UNC内外的学生,研究员和初级教师。随着对指导的要求增加,Wohl博士建议接受正式和非正式的指导,以进一步发展作为导师。此外,为了更好地为他的下属服务,并提高自己的工作效率,他希望获得这个奖项,以加强和提高他的数据收集和分析技能,包括定性和定量数据收集和分析。研究计划:Wohl博士和他的合作者已经建立的研究基础设施,包括建立艾滋病毒感染和未感染的监狱释放者队列,以及他与监狱系统,公共卫生实体和其他研究小组的合作关系,作为一个平台,为学员研究提供充足的机会。在整个艾滋病毒护理梯级中,仍有许多非常重要的问题需要回答,包括:在尊重个人自主权的情况下,进行艾滋病毒筛查和与监狱护理联系的最佳方法是什么?感染艾滋病毒的囚犯在监禁期间受到何种程度的照顾?能否克服顽固的个人障碍(例如,药物滥用、精神健康障碍、积极性低)和结构性障碍(例如,贫穷、歧视、污名化),克服释放后与艾滋病毒护理和服务联系的障碍,如果可以,如何克服?K24的支持将允许沃尔博士有时间从事他研究的自然延伸工作,并为学员研究提供丰富的机会,同时保护时间来支持他对导师的奉献。
英文摘要
DESCRIPTION (provided by applicant): David Alain Wohl, MD, an Associate Professor in the Division of Infectious Diseases at the University of North Carolina (UNC), submits this application for a K24 Mid-Career award. The purpose of the K24 is to enable recipients to: a) Devote more time to augment their capabilities in Patient-Oriented Research (POR); and b) Provide mentoring to new clinical investigators in the conduct of POR. Dr. Wohl is a nationally recognized thought-leader in HIV clinical research - particularly that exploring the nexus between incarceration and HIV. In this application he proposes to develop skills that will serve his future work in this significant area of research including qualitative data collection and analysis methodology, higher-level analytical techniques, and strategies for effective leadership. He will expand an established record of mentorship to develop greater capacity and research opportunities in order to foster the research careers of early investigators. Candidate: Dr. Wohl has been a highly productive HIV clinical researcher and has established UNC as a major center for HIV-related corrections research. Since 2003, he has been continuously NIH-funded to conduct research aiming to optimize HIV detection and care for people involved in the criminal justice system, a population with prevalent substance abuse and mental health disorders, and has directly translated the findings of three R01-supported investigations into modification of practice in the NC prison system. Based on his investigations, the NC prison system has adopted antiretroviral self-medication instead of universal directly observed therapy, shifted to voluntary opt-out HIV testing on intake, and developed new transitional care models for HIV-infected releasees. Further, Dr. Wohl has a strong record of teaching and mentorship of new investigators, supporting procurement of awards and first-authored publications by mentees, as well as independence of these talented investigators. Mentoring Plan/Environment: This application will leverage the extensive training resources at UNC including the Center for AIDS Research (CFAR), the School of Public Health-based K30 training program, the School of Medicine MD/PhD program, and the UNC Infectious Diseases research fellowship - each of which Dr. Wohl is deeply involved with. As a founder and Co-Director of the UNC CFAR Prison Working Group, Site Leader of the UNC AIDS Clinical Trials Unit, and Director of the NC AIDS Training and Education Center (ATEC), Dr. Wohl is well-positioned to access and mentor students, fellows and junior faculty within and beyond UNC. As requests for mentoring have increased, Dr. Wohl proposes to receive formal and informal guidance to develop further as a mentor. Further, to better serve those he supervises and enhance his own productively, he seeks this award to strengthen and enhance his data collection and analytical skills including qualitative and quantitative data collection and analysis. Research Plan: The established research infrastructure Dr. Wohl and his collaborators have built, including the establishment of cohorts of HIV-infected and -uninfected prison releasees, and his collaborative relationships with the prison system, public health entities, and other research groups, serve as a platform to provide ample opportunities for mentee research. There remain a number of highly significant questions to be answered across the cascade of HIV care, including: What are the best methods to conduct HIV screening and linkage to care in prison in a manner respects individual autonomy? To what extent are HIV-infected prisoners engaged in care while incarcerated? Can intransigent individual (e.g., substance abuse, mental health disorders, low motivation) and structural (e.g., poverty, discrimination, stigma) obstacles to linkage to HIV care and services after release be surmounted, and if so, how? The K24 support will permit Dr. Wohl the time to pursue work that are natural extensions of his research, and provide rich opportunities for mentee research while protecting time to support his devotion to mentorship.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:8731476
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:9472311
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
-
批准号:7716751
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: A5235 - MINOCYCLINE IN THE TREATMENT OF HIV-ASSOCIATED COGNITIVE
-
批准号:7716911
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: ENFURVITIDE (T-20) INTENSIFICATION FOR LOW LEVEL VIREMIA (THE LO
-
批准号:7716849
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE C
-
批准号:7716816
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7716808
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: MRK AD5 HIV-1 GAG VACCINE IN HIV-1 SUBJECTS WHO INTERUPT THERAPY
-
批准号:7716792
-
项目类别:
-
资助金额:$1.34万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: PHASE I/II URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY (ACTG A522
-
批准号:7716871
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7679078
-
项目类别:
-
资助金额:$63.58万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7911756
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7338067
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
EZETIMIBE THERAPY FOR DYSLIPIDEMIA IN PATIENTS RECEIVING HIV THERAPY
-
批准号:7625596
-
项目类别:
-
资助金额:$4.69万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
-
批准号:7625507
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE COMBO
-
批准号:7625607
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
POTENT COMBINATION OF ANTIRETROVIRAL REGIMEN IN AFRICAN-AMERICAN MEN AND WOMEN
-
批准号:7625535
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE I/II URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY (ACTG A5229)
-
批准号:7625670
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE II ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASED BONE D
-
批准号:7625543
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE 3 COMPARISON OF LOPINAVIR/RITONAVIR EFAVIRENZ STAVUDINE LAMIVUDINE FOR INI
-
批准号:7625534
-
项目类别:
-
资助金额:$2.75万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7625588
-
项目类别:
-
资助金额:$2.86万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
海外基金